Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03014713Phase 4Unknown
Phase 4, randomised trial of dexmedetomidine in postoperative pain (2 arms). Primary endpoints: Dezocine consumption by patient-controlled analgesia at 24 hours and Pain score at 72 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03014713.